Decrease in the evoked release of endogenous dopamine and dihydroxyphenylacetic acid from rat striatal slices after...

Area of Science:

• Neuroscience
• Pharmacology
• Neurochemistry

Background:

• Chronic haloperidol treatment can induce adaptive changes in the dopaminergic system.
• Understanding these adaptations is crucial for managing side effects and treatment efficacy.

Purpose of the Study:

• To investigate adaptive changes in endogenous dopamine (DA) and DOPAC release in rat striatal slices after chronic haloperidol treatment withdrawal.
• To determine the effects of treatment duration and dosage on DA and DOPAC release.

Main Methods:

• Rat striatal slices were prepared 24 hours after daily haloperidol treatment (2.5 or 10 mg/kg/day for up to 14 days).
• Slices were superfused and stimulated with K+ (50 mM) to measure endogenous DA and DOPAC release.
• DA and DOPAC levels were quantified to assess release and synthesis.

Main Results:

• Short-term haloperidol treatment (3-7 days) decreased K+-stimulated DA release, but 14-day treatment was less effective at the lower dose.
• A higher dose (10 mg/kg) for 14 days significantly reduced DA release.
• K+-stimulated DOPAC release was reduced after 7 or 14 days of treatment at 2.5 mg/kg, and markedly after 3 and 14 days at 10 mg/kg.
• DA content reduction was inconsistent and did not always correlate with DA release.

Conclusions:

• Repeated haloperidol treatment impairs K+-induced stimulation of endogenous DA release and DA synthesis in rat striatum.
• These findings highlight significant adaptive changes in the dopaminergic system following chronic antipsychotic exposure.